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Abstract
Background: In traditional Chinese culture, liver disease is believed to underlie excessive daytime sleepiness (EDS).
Consequently, Chinese patients with complaints of EDS and physicians who treat them suspect that a liver
abnormality is present. If liver disease is ruled out, these patients are often discharged without treatment.
Gastroesophageal reflux disease (GERD) is a common disorder also associated with EDS. This pilot study was
undertaken to determine the prevalence of GERD among Taiwanese patients with complaints of EDS suspected to
be related to liver disease but in whom no evidence for the latter was found.
Methods: From July 2009 to December 2009, 121 outpatients who presented to or were referred to the
Department of Gastroenterology and Hepatology of the Chiayi Gung Memorial Hospital for evaluation of a
complaint of EDS thought to be due to liver disease were examined. Demographic data were collected, and
physical examinations and liver function tests were performed. Forty-eight patients had liver disease and were
excluded. The Chinese Epworth Sleepiness Scale questionnaire (Chinese ESS) and the Chinese Gastroesophageal
Reflux Disease Questionnaire (CGERDQ) were then administered to 73 included patients.
Results: More than half (56.2%) of the included patients were found to suffer from GERD. Patients with symptoms
of GERD had higher mean CGERDQ scores than patients without symptoms of the disorder (18.88 ± 5.49 and 5.56
± 3.57, respectively; P < 0.001). Patients with symptoms of GERD also had higher mean Chinese ESS scores than
patients without symptoms (8.80 ± 5.49 and 3.13 ± 3.50, respectively; P < 0.001). Chinese ESS scores indicative of
EDS were observed in 48.8% of patients with symptoms of GERD and in 3.1% of those without symptoms (P <
0.001). Differences between the two groups retained their significance after controlling for potential confounders.
Conclusions: A significant percentage of Taiwanese patients who complained of EDS and were admitted to our
Hepatology/Gastroenterology Department due to a suspicion of liver disease actually had symptoms of GERD.
Further studies are needed to ascertain whether treatment of GERD will effectively resolve EDS in these patients.
Background
Gastroesophageal reflux disease (GERD) is a common
disorder affecting approximately 10-38% of the adult
population in Western countries and an estimated 17%
of adults living in Xi’an, Shaanxi province in China
[1-3]. Consequences of GERD include, but are not lim-
ited to, Barrett’s esophagus and adenocarcinoma of the
esophagus. In addition, GERD is associated with upper
respiratory disease, adversely affects quality of life
(QOL), and represents a significant economic considera-
tion in terms of treatment costs [1].
Sleepiness, or somnolence, is a complex state influ-
enced by factors such as quantity and quality of prior
sleep, circadian time, medications, and environmental
stimuli as well as by medical, neurological, emotional,
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somnolence is unwanted. Continuous inadequate sleep
negatively impacts cognitive function, physical perfor-
mance, overall well-being, and QOL [4]. The patholo-
gic or inappropriate occurrence of somnolence is
clinically referred to as excessive daytime sleepiness
(EDS) [5].
Sleep contributes to a reduction in normal anti-reflux
mechanisms; rates of swallowing and salivation are
decreased, pressure from the upper and lower esopha-
geal sphincters is decreased, gastric emptying is delayed,
and the “heartburn-signal” is depressed. The supine
position of most sleepers is thought to facilitate gastroe-
sophageal reflux, a major cause of disrupted sleep due
to awakenings from heartburn, dyspepsia, acid brash,
coughing, or choking [5,6]. Not unexpectedly, more
than half of patients with chronic GERD report noctur-
nal symptoms [2-4,7-10]. The consequences of noctur-
nal GERD are thought to exceed those of daytime
GERD in terms of increased risk of esophageal lesions
and respiratory complications, poor QOL, inadequate
sleep, EDS, poor work productivity, and increased costs.
Like daytime GERD, nocturnal GERD can be managed
with surgical therapies or proton pump inhibitors such
that heartburn and regurgitation are reduced concur-
rently with an improvement in sleep.
In addition to GERD, EDS is associated with other co-
morbidities including liver disease [11-17]. Daytime fati-
gue is frequently encountered in patients carrying hepa-
titis virus and in those with primary biliary cirrhosis,
cirrhosis without hepatic encephalopathy, and nonalco-
holic fatty liver disease. In traditional Chinese culture,
liver disease is believed to underlie sleep disorders. Con-
sequently, Chinese patients with complaints of daytime
sleepiness and physicians who treat such patients sus-
pect that a liver abnormality is present. Unfortunately, if
liver disease is ruled out, these patients are often dis-
charged without treatment or follow-up examinations.
The present pilot study was undertaken to determine
the prevalence of GERD among patients who presented
to or were referred to the Department of Gastroenterol-
ogy and Hepatology with complaints of daytime sleepi-
ness suspected to be related to an underlying liver
disease but in whom no evidence for liver disease was
obtained.
Methods
Patients
From July 2009 to December 2009, outpatients who
either presented to or were referred to the Department
of Gastroenterology and Hepatology of the Chiayi Gung
Memorial Hospital for evaluation of a previously unin-
vestigated sleep disorder were included. In Taiwan,
an official referral to a gastroenterology/hepatology
department is not required; therefore patients in this
study were admitted with or without a referral. Exclu-
sion criteria were: previous diagnosis with any type of
sleep disturbance; diagnosis of GERD; current treatment
for GERD by a physician; and previous abnormal liver
function test findings. Patients known to have chronic
h e p a t i t i sBo rCo rt ob ec a r r i e r so fh e p a t i t i sBo rC
were also excluded. Written informed consent was
obtained from all patients, and this study was approved
by the Ethical Committee for Human Clinical Trials of
the Chiayi Gung Memorial Hospital, R.O.C. (Trial Num-
ber 98-2033C).
Demographic data were collected at baseline, includ-
ing information regarding use of medications, alcohol,
and tobacco. A physical examination was performed,
and a blood sample was collected from each patient for
measurements of hepatitis B serum antigen (HBsAg),
anti-HCV Ab, aspartate aminotransferase (AST), and
alanine aminotransferase (ALT). Patients with any
abnormal measurements were then excluded. None of
these patients had a disease history warranting addi-
tional tests (such as a complete blood count). Further-
more, additional tests were not permitted by the
insurance policies of these patients.
Questionnaires
The Chinese Epworth sleepiness scale questionnaire
(Chinese ESS) was administered to all included patients
by the authors. The Chinese ESS is based on the
Epworth sleepiness scale for measurement of daytime
sleepiness; the latter is considered to be the most discri-
minating test for measurement of EDS [18-21]. Designed
for diagnosis of EDS in all Chinese subjects, the Chinese
ESS has been validated for use in Taiwanese and Man-
darin Chinese populations [22]. Specifically, the Chinese
ESS measures the propensity for sleep under a variety of
life-related situations [21]. The questionnaire consists of
eight self-reported questions, with each receiving a score
of 0 to 3. Total possible scores range from 0 (the least
sleepy) to 24 (the most sleepy), with a total score of
5.9 ± 2.2 considered normal for this group of subjects
[19,20]. A score of 10 is indicative of EDS and is consid-
ered the threshold for referral for sleep evaluation [21].
The Chinese Gastroesophageal Reflux Disease Ques-
tionnaire (CGERDQ) was also administered to all
patients included in the study. This questionnaire,
which is designed to identify individuals with symptoms
of gastroesophageal reflux, is comprised of eight ques-
tions. Each question evaluates the frequency and severity
of a symptom of GERD and is scored from 0-3, with a
total score ≥12 serving to indicate the presence of
GERD [23]. The questionnaire has been validated for
use in Chinese subjects and has been shown to be
capable of detecting changes in symptoms [23,24].
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Group comparisons for normally distributed continuous
variables between subjects with and without GERD
symptoms were performed using independent two-sam-
ple t tests. The Chi-square test or Fisher’s exact test was
used for comparisons of categorical variables. Normally
distributed continuous data are presented as means ±
standard deviation whereas categorical data are repre-
sented by numbers and percentage. Stepwise linear
regression analysis was performed to identify the factors
influencing the Chinese ESS. All statistical assessments
were two-sided, with a P value of < 0.05 indicating sta-
tistical significance. Statistical analyses were performed
using SPSS 15.0 statistics software (SPSS Inc., Chicago,
IL, USA).
Results
Between July 2009 and December 2009, 121 consecutive
patients with a primary complaint of EDS were initially
included. In every case, either the patient and/or the
referring practitioner suspected that the complaint was
related to liver disease. Of these, 48 patients were subse-
quently excluded because o ft h ep r e s e n c eo fc h r o n i c
liver disease. Specifically, chronic HBV hepatitis was
found in 12 patients (of which 5 also had fatty liver),
HCV hepatitis was found in 13 patients (of which 6 also
h a df a t t yl i v e r ) ,H B Va n dH CV hepatitis were found to
be present in 1 patient, and fatty liver only was found in
the remaining 22 patients. Seventy-three consecutive
patients without liver disease who presented to or were
referred to the outpatient Hepatology and Gastroenter-
ology Clinic with a primary complaint of EDS were then
selected for this study. The baseline characteristics of
these 73 subjects are presented in Table 1. This group
included 34 (46.6%) males and 39 (53.4%) females ran-
ging in age from 17 to 78 years (mean = 45.75 ± 17.82
years). Based on the results of the CGERDQ, GERD
symptoms were present in 41 (56.2%) of the 73 subjects.
Mean CGERDQ scores in the GERD and non-GERD
groups were 18.88 ± 5.49 and 5.56 ± 3.57, respectively
Table 1 Baseline characteristics of 73 patients with or without gastroesophageal reflux disease as determined by the
Chinese Gastroesophageal Reflux Disease Questionnaire
Total (n = 73) GERD Symptoms (n = 41) No GERD Symptoms (n = 32) P value
Age (years)
a 45.75 ± 17.82 49.95 ± 18.33 45.50 ± 17.43 0.915
Gender, n (%)
b
Male 34 (46.6) 16 (39.0) 18 (56.3) 0.143
Female 39 (53.4) 25 (61.0) 14 (43.8)
BMI (kg/m
2)
a 23.19 ± 3.60 22.95 ± 3.77 23.50 ± 3.41 0.522
Chinese ESS
b
≤10 52 (71.2) 21 (51.2) 31 (96.6) <0.001
>10 21 (28.8) 20 (48.8) 1 (3.1)
CGERDQ score
a 13.04 ± 8.00 18.88 ± 5.07 5.56 ± 3.57 <0.001
Alcohol, n (%)
b
Yes 21 (28.8) 11 (26.8) 10 (31.3) 0.679
No 52 (71.2) 30 (73.2) 22 (68.8)
Smoking, n (%)
b
Yes 22 (30.1) 12 (29.3) 10 (31.2) 0.855
No 51 (69.9) 29 (70.7) 22 (68.8)
Acid suppression, n (%)
b
Yes 18 (24.7) 15 (36.6) 3 (9.4) 0.007
No 55 (75.3) 26 (63.4) 29 (90.6)
Snoring, n (%)
c
Yes 6 (8.2) 6 (14.6) 0 (0.0) 0.032
No 67 (91.8) 35 (85.4) 32 (100.0)
S/H use, n (%)
c
Yes 3 (4.1) 3 (7.3) 0 (0.0) 0.251
No 70 (95.9) 38 (92.7) 32 (100.0)
AST (U/L) 22.10 ± 5.65 21.54 ± 5.88 22.81 ± 5.35 0.342
ALT (U/L) 22.03 ± 6.91 21.56 ± 7.16 22.63 ± 6.63 0.517
Findings are presented either as means ± standard deviation or as numbers (%).
P values were determined from
aindependent two sample t tests,
bChi-square tests, or
cFisher’s exact test.
Abbreviations: BMI, body mass index; Chinese ESS, Chinese Epworth Sleepiness Scale; CGERDQ, Chinese Gastroesophageal Reflux Disease Questionnaire; S/H,
sedatives and/or hypnotics
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patients with positive Chinese ESS scores (>10) as com-
pared to those in the non-GERD group (48.8% versus
3.1%, P < 0.001). The mean Chinese ESS score for sub-
jects with GERD was higher than that for subjects with-
out the disorder (8.80 ± 5.49 versus 3.13 ± 3.50, P <
0.001). Most subjects included in this study did not use
alcohol (71.2%), acid suppression (75.3%), or sedatives/
hypnotics (95.9%). In addition, 69.9% and 91.8%, respec-
tively, of subjects in this study did not smoke or snore.
All subjects were found to be negative for HBsAg and
Anti-HCV Ab, and AST and ALT values for all subjects
were within the normal range.
Simple and multiple linear regression analyses were
performed to identify factors influencing the Chinese
ESS. Findings of these analyses are presented in Table 2.
T h eo n l yv a r i a b l ef o u n dt oi n f l u e n c et h eC h i n e s eE S S
significantly was the CGERDQ score (P < 0.001). After
controlling for the potential confounders of age and
gender, the CGERDQ score remained significantly and
positively associated with the Chinese ESS. The adjusted
R
2 was 0.426, indicating that the statistical modeling
accounted for approximately 43% of the variation in the
Chinese ESS.
Discussion and Conclusion
In this pilot study, 73 Taiwanese subjects with com-
plaints of EDS but for whom no evidence of liver dis-
e a s ew a so b t a i n e dw e r ee x a m i n e df o rt h ep r e s e n c eo f
GERD; remarkably, more than half (56.2%) were found
to suffer from this disorder. Mean CGERDQ scores for
patients with symptoms of GERD (GERD group) were
3.4-fold higher than those for patients without symp-
toms of the disorder (non-GERD group). Patients in the
GERD group were found to have significantly higher
mean Chinese ESS scores than those in the non-GERD
group. Additionally, more patients in the GERD group
had Chinese ESS scores that exceeded 10. The differ-
ences in CGERDQ and Chinese ESS scores between the
GERD and non-GERD groups retained their significance
after controlling for the potential confounders of age
and gender. While a cause and effect relationship
remains to be established, these findings support an
association between GERD and EDS in Taiwanese sub-
jects without liver disease.
The mean ESS score for the entire cohort of patients
examined in this study (6.32 ± 5.49) was comparable to
that reported for the normal community (5.9 ± 2.2)
[19,20] whereas mean scores for patients in the GERD
and non-GERD groups were 8.80 ± 5.49 and 3.13 ±
3.50, respectively. It is unclear why the mean score for
the GERD group fell below that considered to indicate
E D Sa n dw h yt h em e a ns c o r ef o rt h en o n - G E R Dg r o u p
fell below that for the normal community. It is possible
that some of the subjects in this study who claimed to
have EDS did not in fact suffer from more daytime fati-
gue than do members of the local population. Addition-
ally, some patients in this study may have not been
overly concerned about their daytime sleepiness and
therefore presented directly to a gastroenterologist in
preference to a sleep center.
A relationship between GERD and daytime somno-
lence has been described in other studies. For example,
Demeter et al. [4] reported that the severity of GERD as
assessed by panendoscopy and characterized by the
Savary-Miller classification correlated positively with the
degree of daytime somnolence as assessed by the ESS.
Specifically, mild somnolence was observed in 29% of
GERD 0 patients, 39% of GERD I patients, and 46% of
GERD II patients; however 77% of GERD III patients
s u f f e r e df r o ms i g n i f i c a n ts o m n o l e n c e .G u d aet al. [25],
who evaluated 385 consecutive subjects at an outpatient
clinic for sleep disorders, reported that those with a
diagnosis of GERD had significantly higher ESS scores
than those diagnosed without GERD. Furthermore,
Chen et al. [26] reported that patients with nighttime
heartburn complain of significantly greater subjective
sleep impairment as determined by the Pittsburgh Sleep
Quality Index as compared to those without nighttime
heartburn. However, it should be noted that Suurna et
al. [27] observed no differences between patients with
and without nighttime heartburn in any objective sleep
parameter during an overnight polysomnographic study.
In a recently published systematic review of the litera-
ture [10], the mean prevalence of nocturnal GERD was
reported to be 54%. Farup et al. [3], who conducted a
national random-sample telephone survey, reported that
71% of subjects with GERD experienced nocturnal
heartburn. In a separate study [28] of 1,000 individuals
Table 2 Results of simple and multiple linear regression
analyses to identify factors influencing the Chinese
Epworth Sleepiness Scale
Simple Multiple
Coefficient (SE) P value Coefficient (SE) P value
Age 0.004 (0.037) 0.921 -0.005 (0.082) 0.850
Gender 0.842 (1.292) 0.517 1.151 (0.983) 0.246
BMI 0.094 (0.180) 0.605
CGERDQ score 0.454 (0.061) <0.001 0.457 (0.061) <0.001
Alcohol -1.111 (1.422) 0.437
Smoking -2.273 (1.383) 0.105
Acid suppression 1.204 (1.493) 0.423
Snoring 2.017 (2.341) 0.392
S/H use 1.410 (3.252) 0.666
AST 0.027 (0.115) 0.813
ALT -0.023 (0.094) 0.806
Abbreviations: BMI, body mass index; CGERDQ, Chinese Gastroesophageal
Reflux Disease Questionnaire; S/H, sedatives and/or hypnotics
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prevalence of nocturnal heartburn was found to be 79%;
three-quarters of those with nocturnal heartburn
revealed that their heartburn episodes negatively
impacted their sleep. In the present study, the preva-
lence of nocturnal as compared to daytime GERD was
not directly determined. No patient included in this
study complained of nocturnal heartburn but all were
troubled by EDS such that the assistance of a gastroen-
terologist was sought. Based on inquiries conducted
after completion of the questionnaires, it was apparent
that all subjects in the study were likely to have experi-
enced at least light nocturnal heartburn approximately
once weekly. Unfortunately, no accepted questionnaire
is currently available to define the degree of nocturnal
heartburn, and patients in this study were not willing to
submit to measurements of nighttime heartburn with
instruments required for esophageal testing. Future stu-
dies focusing on consequences of nocturnal as opposed
to daytime GERD are indicated; nocturnal symptoms
are associated with significant impairment of health-
related QOL and nocturnal acid reflux is associated with
severe esophagitis, stricture, and esophageal adenocarci-
noma [3,28].
As reviewed by Orr [10], consequences of reflux
events include difficulty initiating sleep, arousals from
sleep, daytime fatigue, and impaired work productivity.
It therefore appears reasonable to consider sleep-related
GERD a distinct clinical entity [10]. Fortunately, GERD
can be effectively managed using such approaches as
head of bed elevation, proton pump inhibitor therapy,
H2 receptor antagonist therapy, and Nissen funoplica-
tion [5]. According to the ProGERD initiatives [2], the
impairment of QOL by GERD can be significantly atte-
nuated or normalized in as little as two weeks by treat-
ment with esomeprazole. In the present study,
significantly more patientsi nt h eG E R Dg r o u pa sc o m -
pared to the non-GERD group utilized acid suppression
(15% as compared to 9.4%, P = 0.007). This finding
further supports the hypothesis that GERD contributes
to EDS in Taiwanese subjects.
The present study is unique in that subjects were
included who complained of EDS rather than symptoms
of GERD. Considering the negative impact of EDS, the
high prevalence of GERD [1,2], and the clear association
between GERD and fatigue [4,7], it would appear pru-
dent for general practitioners to consider GERD as an
underlying contributor to daytime somnolence in
patients with normal liver function. Following a diagno-
sis of GERD, initiation of appropriate therapy and subse-
quent evaluation of that therapy would be indicated. In
support of these recommendations, pantoprazole was
found to provide more significant reductions in reflux
symptoms and ESS scores than placebo after administra-
tion to patients with mild-moderate obstructive sleep-
disordered breathing and GERD [27].
The presence of snoring and sleep apnea are relevant
to an evaluation of EDS. In the present study, 14.6% of
patients in the GERD group but 0% of patients in the
non-GERD group reported snoring. According to
patients in the GERD group, snoring was neither fre-
quent nor severe. However, no tests were performed to
determine either the accuracy of these assessments or
the presence of obstructive sleep apnea in these subjects.
Further research is warranted to determine the relative
extents to which GERD and sleep apnea contribute to
EDS in Taiwanese subjects and other populations.
The most important limitations of this study are the
small sample size, the absence of confirmation of a diag-
nosis of GERD by endoscopy or other appropriate diag-
nostic test, and the lack of a control group. This pilot
study was designed to determine the prevalence with
which Taiwanese patients without liver disease but who
complain of EDS exhibit symptoms of GERD. Further-
more, endoscopy is not routinely performed in hepatol-
ogy clinics in Taiwan. Future randomized, controlled
clinical studies that include a larger number of patients,
an appropriate control group, and tests confirming the
presence of GERD are clearly warranted. In addition,
the present study did not evaluate QOL or social or psy-
chological factors with the potential to contribute to
EDS. Given the demonstrated negative impact of both
GERD and daytime somnolence on QOL, such evalua-
tions are also warranted.
EDS is a common complaint of patients with liver dis-
ease [12-17]. However, Chinese patients with complaints
of EDS but subsequently found to have normal liver
function are often left untreated. In these patients, EDS
persists and the underlying cause is left undiagnosed.
This small pilot study reveals that many patients with
complaints of EDS and who were admitted to our
Department of Hepatology and Gastroenterology due to
a suspicion of liver disease actually had symptoms of
GERD. Further studies are needed to ascertain whether
appropriate treatment of GERD will effectively resolve
EDS in these patients.
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